- Patients
- Clinical Research
- Clinical trials
- Ariceum
Lung Cancer
Ariceum
A multicentre, open-label, phase Ia/Ib study investigating the safety, tolerability and efficacy of 177Lu-SSO110 with companion imaging 68Ga-SSO120 in participants with extensive stage Small Cell Lung Cancer who are on maintenance treatment with Atezolizumab (Ariceum SSO110-01)
Trial overview
Theranostics
Lung
I
Registration number: ACTRN12623000185662
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385299&isReview=true
Murdoch (Oncology)
St John of God Murdoch Hospital, 100 Murdoch Drive, Murdoch, WA, 6150, Australia
(08) 9366 1500 receptiononcologymurdoch@genesiscare.comNuclear Medicine Physician
A/Prof. Joe Cardaci
MBBS, FRACP, AANNMS
Murdoch (Oncology)
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.